NL-OMON27868招募中不适用
The ProBE-AHP study
MUMC+0 个研究点目标入组 300 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Age > 18 years;
- •Signed informed consent;
- •Patients with (suspected) bleeding tendency.
排除标准
- •Pregnancy (or lactating);
- •Active bleeding due to medical interventions or surgical/obstetrical causes.
- •The use of medication which may interfere with diagnostic tests.
研究者
相似试验
进行中（未招募）
1 期
A PROSPECTIVE, OPEN-LABEL STUDY TO ASSESS THE PHARMACOKINETICS, SAFETY & EFFICACY OF ANIDULAFUNGIN WHEN USED TO TREAT CHILDREN WITH INVASIVE CANDIDIASIS, INCLUDING CANDIDEMIA - NDEUCTR2008-004150-32-ITPFIZER60
招募中
不适用
A randomised controlled trial of a continuous butylscopolamine infusion versus a placebo infusion in patients with a renal colic not responding to oral NSAIDsrolithiasisNL-OMON29114Haga teaching hospital128
进行中（未招募）
1 期
A Study to Investigate the Pharmacokinetics (PK) and Safety of Risdiplam in Infants with Spinal Muscular AtrophySpinal Muscular Atrophy (SMA)MedDRA version: 20.1Level: LLTClassification code: 10041583Term: Spinal muscular atrophy unspecified Class: 10010331MedDRA version: 20.1Level: PTClassification code: 10041582Term: Spinal muscular atrophy Class: 100000004850MedDRA version: 20.1Level: LLTClassification code: 10051203Term: Spinal muscular atrophy congenital Class: 10010331CTIS2023-505602-42-00F. Hoffmann-La Roche AG10
已完成
不适用
HEPAPAD StudyI70.29I73.9Peripheral vascular disease, unspecifiedDRKS00016415BT Zotz/Klimas150
尚未招募
2 期
To Study the effects of Unani formulation Habb e Mujarrab in patients with Migraine without auraCTRI/2023/03/050748Central Council for Research in Unani Medicine New Delhi